Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

READI REpresentative Clinical Research - ADvancing Inclusivity in Europe

Coordinator
Servicio Madrileno De Salud, Spain
Runs
1 January 2025 to 31 December 2030
Status
Running
EU funding
€31.5m
Total cost
€68.7m
Partners
89 organisations in 20 countries
Type
Research and Innovation Action
Grant agreement
101166227

What the project is doing

In the project's own words, from its summary on CORDIS.

The public-private partnership, READI, seeks to help clinical studies (CS) to finally serve the complete general population, and therefore more patients. To date CS have struggled to recruit and retain participants from diverse backgrounds and communities, such as marginalized or disadvantaged groups (e.g., sexual, gender, age, cultural, and socioeconomic cohorts). The resulting knowledge gaps entrench or increase health disparities.

The READI consortium strives to tackle these challenges by fostering a more cohesive and integrated CS ecosystem for underserved (US) and underrepresented (UR) communities. It will actively connect all key stakeholders who can facilitate access to a wide range of patient populations. It will provide these stakeholders with the necessary tools, training programs, and approaches essential for the recruitment and retention of US/UR patients in CS.In addition, it will design, build and implement a digital platform which is patient-centred, sustainable, open and innovative.

This will foster improved access to CS information and READI tools, while also supporting patient connections with the created communities. Finally, at least 4 CS will be used for testing the effectiveness of the developed tools and approaches. READI has a three-fold objective: to help US/UR communities overcome CS participation barriers (e.g., lack of information/awareness, mistrust, poor communication, geographic limitations, prejudice), which in turn will improve research of many diseases and conditions, preventative care and treatment effectiveness in different demographic groups, and better serve society.

READI’s success will draw from its interdisciplinary, multi-stakeholder, consortium composition of 88 organizations from 20 countries, with key expertise in drug development and CS (design and operations), engagement strategies for US/UR populations, digital platform development, training and capability building initiatives, effective communication and dissemination, long-term sustainability, ethics and regulatory affairs.

Topics

Who is involved

OrganisationCityCountryRole
Servicio Madrileno De SaludMadridSpainCoordinator
Ablynx NVZwijnaardeBelgiumAssociatedpartner
AmgenDiegemBelgiumParticipant
Cdisc Europe Foundation FondationBruxelles / BrusselBelgiumParticipant
CurewikiBrusselsBelgiumParticipant
Digestive Cancers Europe DiceBruxelles / BrusselBelgiumParticipant
EsperityBruxelles / BrusselBelgiumParticipant
Forum Des Patients EuropeensBruxelles / BrusselBelgiumParticipant
Hl7 EuropeBruxelles / BrusselBelgiumParticipant
Janssen Pharmaceutica NVBeerseBelgiumThird party
Synergist ServicesBruxelles / BrusselBelgiumParticipant
The SynergistBruxelles / BrusselBelgiumParticipant
Ucb BiopharmaBruxelles / BrusselBelgiumParticipant
Sanofi Medley Farmacêutica LtdaSão PauloBrazilAssociatedpartner
F. Hoffmann-La Roche AGBaselSwitzerlandParticipant
Novartis Pharma AGBaselSwitzerlandParticipant
Takeda Pharmaceuticals International AGGlattparkSwitzerlandParticipant
Edex - Educational Excellence Corporation LimitedNicosiaCyprusParticipant
European University - Cyprus LtdNicosiaCyprusParticipant
Abbvie Deutschland GmbH & Co KgWiesbadenGermanyAssociatedpartner
Boehringer Ingelheim InternationalgmbhIngelheimGermanyParticipant
European Aids Treatment Group eVDusseldorfGermanyParticipant
Janssen-Cilag GmbHNeussGermanyThird party
Klinikum Der Universitaet Zu KoelnKoelnGermanyParticipant
Lilly Deutschland GmbHBad HomburgGermanyAssociatedpartner
Aarhus UniversitetAarhus CDenmarkParticipant
Aarhus UniversitetshospitalAarhusDenmarkParticipant
Fonden for Almen Praksis S/iKobenhavn ODenmarkThird party
Midtjyllands EU Kontor ForeningViborgDenmarkParticipant
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Trial NationCopenhagenDenmarkParticipant
Almirall SABarcelonaSpainParticipant
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainThird party
Fundacio Privada per a La Recerca I La Docencia Sant Joan De DeuEsplugues De LlobregatSpainParticipant
Fundacion 29 De FebreroPozuelo De Alarcon MadridSpainParticipant
Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones VicomtechDonostia San SebastianSpainParticipant
Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat ValencianaValenciaSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La PazMadridSpainThird party
Fundacion Para La Investigacion Biomedica Del Hospital Universitario De GetafeMadridSpainThird party
Janssen Cilag SAMadridSpainAssociatedpartner
Pfizer SLUMadridSpainAssociatedpartner
Sanofi Aventis SABarcelonaSpainAssociatedpartner
Synapse Research Management Partners SLMadridSpainParticipant
Zabala Innovation Consulting SAMutilva Alta NavarraSpainParticipant
Ecrin European Clinical Research Infrastructure NetworkParisFranceParticipant
Pfizer International OperationsParisFranceAssociatedpartner
Sanofi R&d VaccinsLyonFranceAssociatedpartner
Sanofi Winthrop IndustrieGentillyFranceAssociatedpartner
Sanofi-Aventis Recherche & DeveloppementGentillyFranceParticipant
Chinoin Private Co LtdBudapestHungaryAssociatedpartner
Eli Lilly Kinsale LtdCorkIrelandAssociatedpartner
Global Heart Hub Company Limited by GuaranteeGalwayIrelandParticipant
Irish Platform for Patients' Organisations Science and Industry Limited by GuaranteeDublinIrelandParticipant
Chiesi Farmaceutici SpAParmaItalyParticipant
Fondazione Penta EtsPadovaItalyParticipant
Socialit Software E Consulting SRLTrentoItalyParticipant
Sanofi SrlMilanoItalyAssociatedpartner
Nacionalinis Vezio InstitutasVilniusLithuaniaParticipant
Pagalbos Onkologiniams Ligoniams AsociacijaKaunasLithuaniaParticipant
Information Technology for Translational Medicine (ittm) SAEsch-UelzechtLuxembourgParticipant

And 29 more organisations. Full list on CORDIS.

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI